⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Sarah TofilonMD

Hematology-Oncology · Fort Dodge, IA 50501

NPI: 1003079997

Share:

11

🟢 Low

🤖 ML Fraud Detection Score: 90%

Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.

Learn more →

Risk Flags

Elevated cost per beneficiaryOpioid + benzodiazepine co-prescriber

Risk indicators are statistical patterns, not allegations. Learn more

1,495

Total Claims

$1.5M

Drug Cost

258

Beneficiaries

$5,993

Cost/Patient

Risk Score Breakdown 11/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid + benzodiazepine combo+8
Cost per patient outlier+3

Score components are additive. Read full methodology

Peer Comparison vs. 8,541 Hematology-Oncology providers

-26%

Opioid rate vs peers

4.6% vs 6.3% avg

-56%

Cost per patient vs peers

$5,993 vs $14K avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

🤖

ML fraud detection score of 90% indicates prescribing patterns with significant similarity to confirmed fraud cases. 18 out of 20 decision trees flagged this provider.

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

4.6%

Opioid Rate

69

Opioid Claims

$1,809

Opioid Cost

17.4%

Long-Acting Rate

Brand vs Generic

100% generic

Brand: 0 claims · $0

Generic: 1,336 claims · $336K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Ibrutinib24$387K
Pomalidomide11$238K
Abiraterone Acetate32$197K
Lenalidomide12$109K
Apixaban41$31K
Anastrozole331$7,548
Exemestane45$6,057
Levothyroxine Sodium53$1,270
Potassium Chloride58$1,112
Fentanyl12$1,076
Gabapentin50$1,043
Hydrocodone/Acetaminophen41$652
Ondansetron Hcl70$642
Prednisone83$626
Dexamethasone40$530

Prescribing Profile

29

Unique Drugs

$417K

IRA Negotiated Drugs

11.0

Anomaly Score

Patient Profile

74

Avg Age

79%

Female

1.75

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About